» Articles » PMID: 37724092

Antimicrobial Resistance Patterns of and Species at the Ethiopian Public Health Institute, Ethiopia: A Five-Year Retrospective Analysis

Overview
Publisher Dove Medical Press
Date 2023 Sep 19
PMID 37724092
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The study aimed to investigate the antimicrobial resistance patterns of and species isolated from clinical specimens over a period of five years, including resistance to methicillin and vancomycin.

Patients And Methods: Bacterial identification and antimicrobial susceptibility testing reports from 2017 to 2021 at the Ethiopian Public Health Institute were used for this retrospective study. The organisms were identified using either BD Phoenix M50, Vitek 2 compact, or conventional biochemical methods, whichever was available at the time of testing. The antimicrobial susceptibility profiles of the isolates were determined using either Kirby-Bauer disc diffusion, BD phoenix M50, or Vitek 2 compact. WHONET software was used to analyze the antimicrobial resistance patterns of both organisms. The p-values of ≤0.05 were considered statistically significant.

Results: During the study period, a total of 315 and 92 species were isolated. Out of 315 isolates, 27% and 5.1% were methicillin and vancomycin resistant, respectively. showed very high resistance to Penicillin G (86.7%). Out of 92 species recovered, 8.7% were vancomycin-resistant. species showed very high resistance to Penicillin G (71.4%) and tetracyclines (83.3%). Methicillin-resistant shows 100% resistance to penicillin followed by ciprofloxacin (50%), erythromycin (45.6%), and tetracycline (44.2%) and lower resistance to vancomycin (18.8%). All vancomycin-resistant isolates of both organisms were fully resistant (100%) to all antibiotics tested, except for linezolid and daptomycin, to which they were susceptible.

Conclusion: This study found a high prevalence of methicillin and vancomycin-resistant and vancomycin-resistant species between 2017 and 2021. However, there were no statistically significant changes in the prevalence of these organisms during the study period. This suggests that larger and more representative nationwide data is needed to show trends of these pathogens.

References
1.
Tefera S, Awoke T, Mekonnen D . Methicillin and Vancomycin Resistant and Associated Factors from Surgical Ward Inpatients at Debre Markos Referral Hospital, Northwest Ethiopia. Infect Drug Resist. 2021; 14:3053-3062. PMC: 8364347. DOI: 10.2147/IDR.S324042. View

2.
Shrestha S, Kharel S, Homagain S, Aryal R, Mishra S . Prevalence of vancomycin-resistant enterococci in Asia-A systematic review and meta-analysis. J Clin Pharm Ther. 2021; 46(5):1226-1237. DOI: 10.1111/jcpt.13383. View

3.
Fiore E, Van Tyne D, Gilmore M . Pathogenicity of Enterococci. Microbiol Spectr. 2019; 7(4). PMC: 6629438. DOI: 10.1128/microbiolspec.GPP3-0053-2018. View

4.
Zhen X, Stalsby Lundborg C, Sun X, Hu X, Dong H . Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrob Resist Infect Control. 2019; 8:137. PMC: 6692939. DOI: 10.1186/s13756-019-0590-7. View

5.
Melese A, Genet C, Andualem T . Prevalence of Vancomycin resistant enterococci (VRE) in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2020; 20(1):124. PMC: 7014939. DOI: 10.1186/s12879-020-4833-2. View